Legal Opinion on the 2022 Annual General Meeting of Shareholders of Yan'an Bikon Pharmaceutical Co., Ltd.
To: Yan'an Bikon Pharmaceutical Co., Ltd.
Jiangsu Fad Dongheng Law Firm (hereinafter referred to as "this firm") has been entrusted by Yan'an Bikon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") to issue this legal opinion in accordance with the Securities Law of the People's Republic of China (hereinafter referred to as "the Securities Law"), the Company Law of the People's Republic of China (hereinafter referred to as "the Company Law"), and the Rules for Shareholders' Meetings of Listed Companies (2022 Revision) (hereinafter referred to as "the Meeting Rules"), as well as other applicable laws, administrative regulations, departmental rules, normative documents, and the current effective Articles of Association of Yan'an Bikon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Articles of Association") within the territory of the People's Republic of China (hereinafter referred to as "China", excluding the Hong Kong Special Administrative Region, Macao Special Administrative Region, and Taiwan).
This firm appointed lawyers to attend the Company's 2022 Annual General Meeting (hereinafter referred to as "this AGM") held on May 25, 2023, to witness the proceedings and provide this legal opinion regarding matters related to this AGM.
To issue this legal opinion, the lawyers of this firm have reviewed the necessary documents, including but not limited to:
- Articles of Association of Yan'an Bikon Pharmaceutical Co., Ltd.
- Resolutions of the 51st Meeting of the 5th Board of Directors
- Resolutions of the 53rd Meeting of the 5th Board of Directors
- Resolutions of the 42nd Meeting of the 5th Supervisory Board
- Notice of the 2022 Annual General Meeting of Yan'an Bikon Pharmaceutical Co., Ltd. (Announcement No.: 2023-074)
- Announcement on the Postponement of the 2022 Annual General Meeting of Yan'an Bikon Pharmaceutical Co., Ltd. (Announcement No.: 2023-085)
- Notice of the 2022 Annual General Meeting of Yan'an Bikon Pharmaceutical Co., Ltd. (Postponed) (Announcement No.: 2023-086)
- Announcement on the Change of Venue for the 2022 Annual General Meeting of Yan'an Bikon Pharmaceutical Co., Ltd. (Announcement No.: 2023-089)
- Shareholder register as of the record date for this AGM
- Attendance registration records and supporting documents of shareholders present at the meeting
- Statistical results of online voting for this AGM
- Other meeting documents related to this AGM
The Company has assured this firm that it has disclosed all facts that could affect the issuance of this legal opinion and provided all original written materials, copies, letters of commitment, or certificates required for the issuance of this legal opinion. There are no omissions, false statements, or significant omissions; the documents and materials provided to this firm are true, accurate, complete, and valid, and if the documents are copies or reproductions, they are consistent with the originals.
In this legal opinion, this firm only expresses opinions on the procedures for convening and holding this AGM, the qualifications of the shareholders attending this AGM, the qualifications of the convener, and whether the voting procedures and results comply with relevant laws, administrative regulations, the Meeting Rules, and the Articles of Association. This firm does not express opinions on the content of the proposals reviewed at this AGM or the truthfulness and accuracy of the facts or data stated in those proposals. This firm only expresses opinions based on current effective laws and regulations within China and does not express opinions based on any laws outside of China.